Affluent Medical SA

EPA:AFME.PA

1.765 (EUR) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920172016
Operating Activities:
Net Income -15.653-15.227-14.82-14.319-16.589-8.752-5.837
Depreciation & Amortization 2.4132.3482.3322.4652.260.3530
Deferred Income Tax 00-1.514-0.428-5.15100
Stock Based Compensation 0.7310.1460.0420.9590.43700
Change In Working Capital 0.2350.717-1.1360.612-0.091-2.4430
Accounts Receivables 0.466-1.337-1.0021.728-0.194-0.0430
Inventory 000-0.001000
Accounts Payables 0.3521.227-0.558-1.352000
Other Working Capital -0.5830.8270.4240.2370.103-2.4630
Other Non Cash Items 4.8920.9352.7321.7756.9470.7475.837
Operating Cash Flow -12.121-11.081-12.364-8.936-12.187-10.8420
Investing Activities:
Investments In Property Plant And Equipment -0.184-0.146-0.334-0.304-0.199-0.2630
Acquisitions Net 000.17400.01400
Purchases Of Investments 00000-0.0070
Sales Maturities Of Investments 0000000
Other Investing Activites -0.18400.17400.014-0.0380
Investing Cash Flow -0.184-0.146-0.16-0.304-0.185-0.270
Financing Activities:
Debt Repayment -1.066-2.469-2.1234.1887.3562.850
Common Stock Issued 12.5535.74221.4257.4670.0559.2170
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -0.104-0.87220.4041.1073.032.2890
Financing Cash Flow 11.3832.40118.28112.76211.16114.3560
Other Information:
Effect Of Forex Changes On Cash 00003.3370.0010
Net Change In Cash -0.922-8.8265.7573.522-2.7493.2450
Cash At End Of Period 1.6582.57911.4055.6482.1264.8750